Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TS ID 10085]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
MT684 Smart Peak Flow for monitoring asthmaStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC